The Journal of Bone and Mineral Metabolism (JBMM) publishes:
(1) Original articles
(2) Review articles
(4) Letter to Editor
Manuscripts are received with the understanding that they have not been published or submitted for publication in whole or part elsewhere. This restriction does not apply to abstracts published in connection with scientific meetings. All papers are reviewed by at least two referees, and acceptance is decided by the editorial board of the Japanese Society for Bone and Mineral Research and the Japanese Society for Bone Morphometry.
Editorial Office, Journal of Bone and Mineral Metabolism
c/o Academic Square Co., Ltd.
2-348-302 Ryogae-machi, Fushimi-ku, Kyoto 612-8082, Japan
Tel 81-75-468-8772; Fax 81-75-468-8773
Prerequisites for publication: A Certification Form, included in each issue, and which also may be downloaded from: http://www.springer.com/774, must be signed by all authors and be scanned and uploaded through Editorial Manager at the same time you submit your manuscript.
IMPORTANT: Upon receipt of a Certification Form, manuscripts are officially recognized as submissions.
Authors should submit their manuscripts to JBMM online. Please log in directly at: https://www.editorialmanager.com/jbmm and upload your manuscript following the instructions given. If you encounter any difficulties while submitting your manuscript online, click on Help in the upper left corner.
Authors entering the journal’s Editorial Manager site can either create a new account or use an existing one. When you have an existing account, use it for all your submissions;
you can track their status on the same page.
If you have forgotten your username and password, please click the link “Send Username/Password” and enter your mail address. You will then receive an automatic e-mail with your user name and password. Alternatively, please create a new account and then follow the instructions given on the screen.
Once you have logged into your account, Editorial Manager will lead you through the submission process in an orderly, step-by-step process. If you cannot finish your submission in one visit, you can save a draft and re-enter the process later at the same point for that manuscript.
While submitting your electronic manuscript, you will be required to enter data about your manuscript in the system. These include full title, author names and affiliations, and so forth, as listed below under Preparation of Manuscripts. Support for special characters is available.
Main Documents: Main documents of articles should be uploaded in rich text format (.rtf) or as a Microsoft Word document (.doc).
Tables: Use the table functions of your word-processing
program, not spreadsheets, to make tables. Tables may be uploaded separately from the main document or inserted into
the main document.
Figures: Common graphic files such as GIF, JPEG, EPS, and TIFF are supported. Please upload figures that are satisfactory for the review process. If your manuscript is accepted for publication, you will be required to provide figures/illustrations of sufficient quality for printing according to Requirements for Electronically Produced Illustrations for Accepted Papers toward the end of these instructions.
After uploading the parts of the article in this manner, the system will convert the files to PDF format. You can view the result of the conversion with Adobe Acrobat Reader. You will also be notified by e-mail that your submission was successful.
At any point during this process, there are Help buttons available to see frequently asked questions.
If the total size of the files exceeds the file volume (20 MB) for online submission, reduce the resolution of large files for initial submission.
All human studies must be conducted according to the Declaration of Helsinki principles. Authors should include a statement that the studies have been approved by the appropriate institutional review board(s) (IRB), together with a statement that written informed consent was received from participants prior to inclusion in the study.
For animal studies, authors should state that the studies have been approved by the appropriate institutional review board(s) and conducted according to all applicable institutional and/or national guidelines for the care and use of animals.
These statements should be included in an independent paragraph in the Methods section of the manuscript. Manuscripts without the paragraph will not be reviewed.
All individuals have individual rights that are not to be infringed. Individual participants in studies e.g. have the right to decide what happens to the (identifiable) personal data gathered and to what they have said e.g. during a study or an interview as well as to any photograph that was taken. Hence it is important that all participants gave their informed consent in writing prior to inclusion in the study. Identifying details (names, dates of birth, identity numbers and other information) of the participants that were studied should not be published in written descriptions, photographs, and genetic profiles unless the information is essential for scientific purposes and the participant (or parent or guardian if the participant is incapable) has given written informed consent for publication. Complete anonymity is difficult to achieve in some cases, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of participants is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic profiles, authors should provide assurance that alterations do not distort scientific meaning.
The following statement should be included:
Informed consent: “Informed consent was obtained from all individual participants included in the study.”
If identifying information about participants is available in the article, the following statement should be included:
“Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.”
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements dealing with ethical concerns. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
Manuscripts should be double-spaced. Leave margins of approximately 3 cm on the sides, top, and bottom of the page.
Three manuscript pages correspond to about one printed page. The title page should include the authors’ names, addresses, and affiliations. Please indicate the name, address, phone number, fax number, and e-mail address of the author who is to receive correspondence. Provide up to five key words.
Articles should have the following format: Title page, text, conflict of interest, references, tables, figure legends, and artwork. Number pages consecutively. Consult a current issue of the journal for the exact format.
1. Original Articles
Articles should have the following format: Title page, abstract, main text, author contributions, acknowledgments, references, tables with footnotes, figure legends, and figures. Number pages consecutively. Consult a current issue of the journal for the exact format.
Title should be clear, concise, informative, and limited to no more than 15 words. For publication, titles may be revised by the JBMM to ensure clarity and accessibility to our readers, with the final approval of the authors.
Provide a structured abstract of no more than 250 words which should be divided into the following sections:
- Materials and Methods
Main text including Introduction, Materials and Methods, Results, and Discussion should be limited to 5,000 words.
Provide acknowledgments and author contributions, specifying how each author (identified by initials) contributed to the manuscript.
Up to 50 References should be provided.
Tables are self-contained and self-explanatory with brief titles.
Figures and Figure legends, provide a short title and an explanation in brief but sufficient detail to make the figure intelligible without reference to the main text
Figures and Tables should be no more than 7 items.
Supplemental data, authors may provide related supplemental data.
2. Review Articles
The editorial board invites selected investigators to submit review articles. Unsolicited reviews are also acceptable pending peer review by the editorial board.
Title should be clear, concise and limited to no more than 10 words.
Abstracts or a concluding summary should be no more than 200 words.
Main text should be no more than 3000 words. Reference should be limited to no more than 50.
Figures and Tables should be no more than 5 items.
All Review Articles, whether invited or not, will be subject to peer review.
Perspectives are more focused than reviews and may be accepted from a single individual or team. Perspectives may be solicited or proposed. Proposed perspectives must be approved by the Editor-in-Chief prior to submission.
JBMM will not review perspectives that have not been approved by the Editor-in-Chief. Perspectives should review a particular field to identify outstanding issues and challenges and propose new hypotheses.
Please note that any Perspective will be subject to the standard review process.
4. Letters to the Editor
Letters to the Editor should contribute constructively and substantively to scientific dialogue, and should concern timely and important issues raised in articles recently published in the JBMM. Letters to the Editor should not exceed 400 words.
No more than 5 references may be provided, and the first one must be the original article under discussion. If necessary, one figure or table may be included.
Prepare each table (with its title) on a separate page. Use Arabic numerals to number tables. Each table must be able to stand alone, i.e., it must contain enough information to be understood independently of the text. Details of experimental conditions, statistical significance, and the definition of all abreviations should be included in the table footnotes. Information that appears in the text should not be repeated in detail in the tables, and tables should not contain data that can be given in the text in one or two sentences.
All figures are to be numbered using Arabic numerals. Figure parts should be denoted by lowercase letters (a, b, c, etc.). If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure captions and citations.For all figures, double-spaced figure legends should be supplied on a separate page. Magnifications should be included when appropriate, and all abbreviations must be defined.
All tables and figures must be cited in order in the text.
If a figure has been published previously, acknowledge its source and submit written permission from the author and publisher. The previously published source should also be included in the list of references.
Abbreviations and nomenclature should follow the recommendations of the International Union of Pure and Applied Chemistry and the International Union of Biochemistry at the web sites, http://www.chem.qmul.ac.uk/iupac/jcbn/. All quantities stated should conform to the International System of Units (SI units). The list of abbreviations in Endocrinology 138: 1 (January 1997) is generally acceptable in JBMM. Drug names should always be generic. Please give the name and location (city, state, country) of the manufacturer of any equipment referred to in your manuscript.
Number references consecutively in the order cited in the text using square brackets:—as shown by Suzuki et al. , Fujita et al. , Brown and Roberts .
References should be listed in numerical order at the end of the article. References should include the names of all authors when 19 or less; when 20 or more, list only the first 5 names and add et al.
References should also include the full title. Journal titles should be abbreviated according to Index Medicus and inclusive page numbers should be supplied.
The styling of the reference list for
2.journal articles in Japanese
4.and chapters in edited books
is as follows:
1. Tezuka K, Wada Y, Takahashi A (2005) Computersimulated bone architecture in a simple bone-remodeling model based on a reaction-diffusion system. J Bone Miner Metab 23:1–7
2. Ishida Y (1998) Studies on induction mechanism of ossification of the posterior longitudinal ligament of the spine especially on the cultured cells from the human spinal ligament (in Japanese). Nippon Seikeigeka Gakkai Zasshi (J Jpn Orthop Assoc) 62:1019–1027
3. Takahashi HE (1999) Mechanical Loading of Bones and Joints. Springer, Tokyo
4. Suzuki F (1994) Regulation of cartilage differentiation and metabolism. In: Heersche JNM, Kanis JA (eds) Bone and Mineral Research 8. Elsevier, Amsterdam, pp 115–142
• Indicate what graphics program was used to create the artwork.
• For vector graphics, the preferred format is EPS; for halftones, please use
TIFF format. MS Office files are also acceptable.
• Vector graphics containing fonts must have the fonts embedded in the
• Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.
• Definition: Black and white graphic with no shading.
• Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
• All lines should be at least 0.1 mm (0.3 pt) wide.
• Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
• Vector graphics containing fonts must have the fonts embedded in the files.
• Definition: Photographs, drawings, or paintings with fine shading, etc.
• If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
• Halftones should have a minimum resolution of 300 dpi.
• Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
• Combination artwork should have a minimum resolution of 600 dpi.
• Color art is free of charge for online publication.
• If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary
distinctions between the different colors are still apparent.
• If the figures will be printed in black and white, do not refer to color in the captions.
• Color illustrations should be submitted as RGB (8 bits per channel).
• To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
• Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
• Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
• Avoid effects such as shading, outline letters, etc.
• Do not include titles or captions into your illustrations.
• All figures are to be numbered using Arabic numerals.
• Figures should always be cited in the text in consecutive numerical order.
• Figure parts should be denoted by lowercase letters (a, b, c, etc.).
• If an appendix appears in your article/chapter and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures, "A1, A2, A3, etc." Figures in online appendices (Electronic supplementary Material) should, however, be numbered separately.
• Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
• Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
• No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
• Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
• Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.
Figure Placement and Size
• When preparing your figures, size figures to fit in the column width.
• For most journals the figures should be 39 mm, 84 mm, 129 mm, or 174 mm wide and not higher than 234 mm.
• For books and book-sized journals, the figures should be 80 mm or 122 mm wide and not higher than 198 mm.
If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.
In order to give people of all abilities and disabilities access to the content of your figures, please make sure that
• All figures have descriptive captions (blind users could then use a text-to speech software or a text-to-Braille hardware)
• Patterns are used instead or in addition to colors for conveying information (color-blind users would then be able to distinguish the visual elements)
• Any figure lettering has a contrast ratio of at least 4.5:1.
Authors are required to disclose commercial or similar relationships to products or companies mentioned in or related to the subject matter of the article being submitted. Affiliations of authors should include corporate appointments relating to or in connection with products or companies mentioned in the article, or otherwise bearing on the subject matter thereof. Sources of funding for the article should be included in the acknowledgments. Other pertinent financial relationships, such as consultancies, stock ownership, or other equity interests or patent-licensing arrangements, should be disclosed in the cover letter to the Editor-in-Chief, on a separate conflict of interest page in the manuscript (see below for examples of how to format the conflict of interest page in your manuscript) and on the conflict of interest form accompanying the article at the time of submission. The conflict of interest form, which is available at: http://www.springer.com/774, should be signed, scanned, and submitted through Editorial Manager. The conflicts of interest disclosed on the conflict of interest form should be the same as those disclosed on the conflict of interest page in the manuscript. Questions about this policy should be directed to the Editor-in-Chief.
Please note: When considered necessary, the raw data of a manuscript will be requested to be submitted and examined by a third-party.
The conflict of interest page should take the form of a statement as shown in the following examples.
- Dr. YYYYY serves as a consultant for Company X.
- Dr. XXXXX is an employee of Company Y.
- Dr. XXXXX owns stock in Company Z.
- All other authors have no conflicts of interest.
- If no author has a conflict, the statement should read “All authors have no conflicts of interest.”
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation can be achieved by following the rules of good scientific practice, which include:
• The manuscript has not been submitted to more than one journal for simultaneous consideration.
• The manuscript has not been published previously (partly or in full), unless the new work concerns an expansion of previous work (please provide transparency on the re-use of material to avoid the hint of text-recycling (“self-plagiarism”)).
• A single study is not split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (e.g. “salami-publishing”).
• No data have been fabricated or manipulated (including images) to support your conclusions
• No data, text, or theories by others are presented as if they were the author’s own (“plagiarism”). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks are used for verbatim copying of material, and permissions are secured for material that is copyrighted.
Important note: the journal may use software to screen for plagiarism.
• Consent to submit has been received explicitly from all co-authors, as well as from the responsible authorities - tacitly or explicitly - at the institute/organization where the work has been carried out, before the work is submitted.
• Authors whose names appear on the submission have contributed sufficiently to the scientific work and therefore share collective responsibility and accountability for the results.
• Authors are strongly advised to ensure the correct author group, corresponding author, and order of authors at submission. Changes of authorship or in the order of authors are not accepted after acceptance of a manuscript.
• Adding and/or deleting authors and/or changing the order of authors at revision stage may be justifiably warranted. A letter must accompany the revised manuscript to explain the reason for the change(s) and the contribution role(s) of the added and/or deleted author(s). Further documentation may be required to support your request.
• Requests for addition or removal of authors as a result of authorship disputes after acceptance are honored after formal notification by the institute or independent body and/or when there is agreement between all authors.
• Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential proprietary data is excluded.
If there is a suspicion of misconduct, the journal will carry out an investigation following the COPE guidelines. If, after investigation, the allegation seems to raise valid concerns, the accused author will be contacted and given an opportunity to address the issue. If misconduct has been established beyond reasonable doubt, this may result in the Editor-in-Chief’s implementation of the following measures, including, but not limited to:
• If the article is still under consideration, it may be rejected and returned to the author.
• If the article has already been published online, depending on the nature and severity of the infraction, either an erratum will be placed with the article or in severe cases complete retraction of the article will occur. The reason must be given in the published erratum or retraction note. Please note that retraction means that the paper is maintained on the platform, watermarked "retracted" and explanation for the retraction is provided in a note linked to the watermarked article.
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to.
The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.
The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines*:
All authors whose names appear on the submission
1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;
2) drafted the work or revised it critically for important intellectual content;
3) approved the version to be published; and
4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate).
The decision whether such information should be included is not only dependent on the scope of the journal, but also the scope of the article. Work submitted for publication may have implications for public health or general welfare and in those cases it is the responsibility of all authors to include the appropriate disclosures and declarations.
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations. Please check the Instructions for Authors of the Journal that you are submitting to for specific instructions.
Role of the Corresponding Author
One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed.
The Corresponding Author is responsible for the following requirements:
ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors;
managing all communication between the Journal and all co-authors, before and after publication;*
providing transparency on re-use of material and mention any unpublished material (for example manuscripts in press) included in the manuscript in a cover letter to the Editor;
making sure disclosures, declarations and transparency on data statements from all authors are included in the manuscript as appropriate (see above).
* The requirement of managing all communication between the journal and all co-authors during submission and proofing may be delegated to a Contact or Submitting Author. In this case please make sure the Corresponding Author is clearly indicated in the manuscript.
Please check the Instructions for Authors of the Journal that you are submitting to for specific instructions regarding contribution statements.
In absence of specific instructions and in research fields where it is possible to describe discrete efforts, the Publisher recommends authors to include contribution statements in the work that specifies the contribution of every author in order to promote transparency. These contributions should be listed at the separate title page.
Examples of such statement(s) are shown below:
• Free text:
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [full name], [full name] and [full name]. The first draft of the manuscript was written by [full name] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
For review articles where discrete statements are less applicable a statement should be included who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work.
For articles that are based primarily on the student’s dissertation or thesis, it is recommended that the student is usually listed as principal author:
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may additionally be stated. Addresses will not be updated or changed after publication of the article.
Changes to authorship
Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not accepted after acceptance of a manuscript.
Please note that author names will be published exactly as they appear on the accepted submission!
Please make sure that the names of all authors are present and correctly spelled, and that addresses and affiliations are current.
Adding and/or deleting authors at revision stage are generally not permitted, but in some cases it may be warranted. Reasons for these changes in authorship should be explained. Approval of the change during revision is at the discretion of the Editor-in-Chief. Please note that journals may have individual policies on adding and/or deleting authors during revision stage.
Authors are recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.
Deceased or incapacitated authors
For cases in which a co-author dies or is incapacitated during the writing, submission, or peer-review process, and the co-authors feel it is appropriate to include the author, co-authors should obtain approval from a (legal) representative which could be a direct relative.
Authorship issues or disputes
In the case of an authorship dispute during peer review or after acceptance and publication, the Journal will not be in a position to investigate or adjudicate. Authors will be asked to resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a manuscript from the editorial process or in case of a published paper raise the issue with the authors’ institution(s) and abide by its guidelines.
Authors should treat all communication with the Journal as confidential which includes correspondence with direct representatives from the Journal such as Editors-in-Chief and/or Handling Editors and reviewers’ reports unless explicit consent has been received to share information.